Cotesting, the practice of adding cytology to human papillomavirus (HPV) screening, offered little added benefit over HPV testing alone in the detection of precancer among women aged 25-65 years, ...
Among women older than 65 years who were at a high risk for cervical cancer and required screening, only 5.2% received appropriate screening. Women with a history of high-grade cervical dysplasia had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results